Eva Thijssen

6PUBLICATIONS
19CO-AUTHORS
Gene and molecular therapyClinical pharmacology and therapeuticsPharmacogenomicsToxicology (incl. clinical toxicology)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 14, 2026
Preclinical and clinical investigation of VES001, an oral small molecule sortilin receptor inhibitor for the treatment of frontotemporal dementia: a first-in-human randomized placebo-controlled phase 1 trial.

|May 07, 2024
Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients.

Eva Thijssen, Bert Tuk, Michel Cakici

|Jul 04, 2023
Treatment Detection and Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Part III Estimation Using Finger Tapping Tasks.

Ahnjili ZhuParris, Eva Thijssen, Willem O Elzinga

|Nov 07, 2022
A Placebo-Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's Disease.

Eva Thijssen, Soma Makai-Bölöni, Emilie van Brummelen

|Apr 15, 2022
A Randomized First-in-Human Study With UB-312, a UBITh® α-Synuclein Peptide Vaccine.

Hui Jing Yu, Eva Thijssen, Emilie van Brummelen

|Jan 20, 2022
A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ-009.

Eva Thijssen, Jonas den Heijer, David Puibert

Pageof 1

Frequent Collaborators

4 joint publications

Geert Jan Groeneveld

2 joint publications

Jonas den Heijer

2 joint publications

Soma Makai-Bölöni

2 joint publications

Robert-Jan Doll